EDWARDS PREVIEWS MINIMALLY INVASIVE HEART MONITOR.Edwards Lifesciences Corporation (NYSE NYSE See: New York Stock Exchange :EW), Phoenix, a global leader in hemodynamic monitoring hemodynamic monitoring Clinical medicine A general term for the ongoing evaluation of hemodynamics technologies, has previewed its Edwards FloTrac sensor, a new minimally invasive hemodynamic monitoring invasive hemodynamic monitoring Cardiology Any maneuver used to measure in vivo hemodynamics: arterial line(s), pulmonary artery catheter, central venous line, and cardiac output monitoring. See Interventional cardiology. device, at the Society of Critical Care Medicine's (SCCM SCCM Society of Critical Care Medicine SCCM System Center Configuration Manager (Microsoft) SCCM Standard Cubic Centimeters per Minute SCCM Software Change and Configuration Management SCCM South Carolina Columbia Mission ) 34th Critical Care Congress. Clinicians monitored patients' cardiovascular performance with a variety of hemodynamic monitoring tools, depending upon a patient's condition. In critical and intensive care settings, clinicians need to monitor cardiac output cardiac output n. Abbr. CO The volume of blood pumped from the right or left ventricle in one minute. It is equal to the stroke volume multiplied by the heart rate. , including oxygen saturation oxygen saturation sO2 The O2 concentration of blood expressed as a ratio of its total O2-carrying capacity; the OS is a measure of the utilization of O2 transport capacity; sO2 levels, blood pressure and blood volume, preferably on a continuous basis. Traditionally, these critical parameters have been gathered through pulmonary artery catheters that are threaded into a patient's heart. Edwards, which pioneered pulmonary artery catheter technologies and is the world's leading hemodynamic monitoring company, developed the FloTrac sensor so clinicians could gauge some of these patient parameters less invasively. The Edwards FloTrac sensor provides certain key continuous cardiac measurements by accessing data directly from an arterial line arterial line n. An intra-arterial catheter. , which is a small catheter inserted into the patient's radial artery radial artery n. 1. An artery with its origin in the brachial artery and with branches to the radial recurrent, dorsal metacarpal, and dorsal digital arteries, the principal artery of the thumb, the palmar metacarpal, and muscular and carpal . Most critically ill or surgical patients in hospitals already have an arterial line in place to measure basic cardiovascular information and to draw blood, making the FloTrac sensor very easy to use. The sensor's unique technological platform enables clinicians to elect a less-invasive option for those patients who need hemodynamic monitoring, but who may not require all of the parameters offered by Edwards' line of Swan-Ganz catheters. "Edwards' Swan-Ganz catheter is considered the 'gold standard' for conventional hemodynamic monitoring," said Anita B. Bessler, Edwards corporate vice president, global franchise management. "We developed the FloTrac technology to enable clinicians to assess hemodynamic he·mo·dy·nam·ics n. (used with a sing. verb) The study of the forces involved in the circulation of blood. he parameters for a broader population of patients who could benefit from monitoring but who traditionally are not candidates for the more invasive existing technology. "Initial clinician feedback from FloTrac sensor pilot studies has been very positive," Bessler added, "and we expect to make this product widely available in the U.S. and Europe later this year, pending the appropriate regulatory approvals." Gerard R. Manecke, Jr., M.D., clinical professor in UC San Diego School of Medicine's department of anesthesiology, reported at the SCCM that a preliminary study of 11 heart surgery patients demonstrated that the FloTrac sensor provided a reliable, minimally invasive method for measuring cardiac output, when compared with the Swan-Ganz catheter. Edwards Highlights Latest Critical Care Monitoring Technologies In addition to previewing its FloTrac sensor, Edwards also has launched its new Vigilance II monitor, the next generation of continuous cardiac output and oximetry oximetry /ox·im·e·try/ (ok-sim´e-tre) determination of the oxygen saturation of arterial blood using an oximeter. oximetry (oksim´itrē), n monitors for use with Swan-Ganz catheters. The Vigilance II monitor features a streamlined design, as well as a large, color, customizable display. The Vigilance II monitor also offers clinicians a unique data graph, which can simplify complex data and provide a clearer picture of hemodynamic performance, thereby allowing clinicians to more easily assess a patient's condition. Edwards' PreSep central venous oximetry catheter, which serves as an integral part of Early Goal-Directed Therapy for managing sepsis, also was highlighted in several scientific sessions at SCCM. Edwards featured its PreSep catheter, along with the FloTrac sensor and the Vigilance II monitor, at SCCM. About Edwards Lifesciences Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease Peripheral Vascular Disease Definition Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms. and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, Fogarty, LifeStent, PERIMOUNT and Swan-Ganz. For more information, call 949/250-5070 or visit http://www.edwards.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion